Remdesivir,also known by its trade name VEKLURY®,is a RNA-dependent RNA polymerase (RdRp) inhibitor developed by Gilead Sciences.

Nektar Therapeutics has launched a Phase 2b trial to assess Rezpegaldesleukin in individuals with severe forms of Alopecia Areata.

Paracetamol, known by its alternate name acetaminophen, is a common analgesic and antipyretic used to reduce fever and alleviate pain.

Ankyra Therapeutics has commenced dosing in its initial human trial phase, assessing the effectiveness of ANK-101, a novel anchored immunotherapy, targeting a range of solid cancers.

Guanfacine (Brandname Tenex、Intuniv、Estulic) is a medication that acts as a centrally acting antihypertensive agent and an α2-adrenoceptor agonist.

Novartis unveils fresh insights into Zolgensma's safety and performance, highlighting sustained and enhanced motor skills in SMA-affected children who are larger and older.

Niacin is a type of B vitamin.niacin can boost levels of good HDL cholesterol and lower triglycerides.

Cullinan Oncology Reveals FDA Approval for Initial Trials of Unique MICA/B Antibody, CLN-619, Targeting Advanced Multiple Myeloma Cases.

Buprenorphine Hydrochloride, approved in the US in 1981, is made by Indivior and used for pain management when other treatments are inadequate.

ATA3219, an off-the-shelf CAR T treatment by Atara Biotherapeutics, gets green light from the FDA for its IND submission targeting Lupus Nephritis.

Aspirin, also known as acetylsalicylic acid (ASA), is a widely used nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain, fever, and inflammation while also acting as an antithrombotic.

UK regulators have approved Ariceum Therapeutics to initiate an early-stage trial with its innovative I-123 tagged PARP blocker for individuals experiencing repeated glioblastoma.